Actor
Olgram
Olgram is a biotechnology company developing 2 programs :
– a first in class molecule with the unique property to cure immune diseases with original target and mechanism of action allowing, in validated in vivo POC, to cure the immunodepression post-traumatic brain injury (750 000 patients per year USA/Europe, no therapeutic solution yet).
– a new class of anti-infectives that target the “sleeping” bacteria responsible for relapse and recalcitrance of the disease (3.6million patients per year).
The company has also discovered an associated biomarker (inclusion of 170 patients) allowing us to anticipate which patients will suffer from immunodepression after different types of traumas.
Specialties
Primary Therapeutic Areas
1.08 Other Diagnostic & Therapeutic
1.10 Small Molecules
1.54 Drug Discovery & Delivery
2.10 Agricutlure & Bio
2.13 Nutraceuticals
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Immunology & Allergy, Infectious Diseases
Main sector
Biotech
Contact
c/o FONGIT, Route de la Galaise 34
1228 Plan les Ouates / GE
+41782177405